IHAM
EXEL icon

Integral Health Asset Management’s Exelixis EXEL Stock Holding History

Integral Health Asset Management’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100,000
Closed -$1.72M – 70
2020
Q1 		$1.72M Buy
+100,000
New +$1.83M 0.76% 41

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Integral Health Asset Management's EXEL Position: Q2 2021 in Review

Integral Health Asset Management sold out of Exelixis (EXEL) in Q2 2021, closing a stake of 200,000 shares — an estimated $4.52M sold.

Integral Health Asset Management first reported a position in EXEL in Q1 2020 and held it in 3 quarters. The position peaked at $4.52M in Q1 2021. 345 funds tracked by Wall St. Rank hold EXEL as of Q2 2021.

  • Integral Health Asset Management reported no remaining Exelixis position as of Q2 2021 after selling out during the quarter.
  • Integral Health Asset Management sold 200,000 Exelixis shares in Q2 2021, an estimated $4.52M.
  • Integral Health Asset Management first reported a position in Exelixis in Q1 2020 and held it in 3 quarters.
  • Integral Health Asset Management's Exelixis position peaked at $4.52M in Q1 2021.
  • 345 funds tracked by Wall St. Rank held Exelixis as of Q2 2021.

Based on Integral Health Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.